File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1042/bj2610253
- Scopus: eid_2-s2.0-0024391193
- PMID: 2775212
- WOS: WOS:A1989AE78400037
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Changes in collagen stability and folding in lethal perinatal osteogenesis imperfecta. The effect of α1(I)-chain glycine-to-arginine substitutions
Title | Changes in collagen stability and folding in lethal perinatal osteogenesis imperfecta. The effect of α1(I)-chain glycine-to-arginine substitutions |
---|---|
Authors | |
Issue Date | 1989 |
Publisher | Portland Press Ltd. The Journal's web site is located at http://www.biochemj.org |
Citation | Biochemical Journal, 1989, v. 261 n. 1, p. 253-257 How to Cite? |
Abstract | The effect of glycine-to-arginine mutations in the α1(I)-chain on collagen triple-helix structure in lethal perinatal osteogenesis imperfecta was studied by determination of the helix denaturation temperature and by computerized molecular modelling. Arginine substitutions at glycine residues 391 and 667 resulted in similar small decreases in helix stability. Molecular modelling suggested that the glycine-to-arginine-391 mutant resulted in only a relatively small localized disruption to the helix structure. Thus the glycine-to-arginine substitutions may lead to only a small structural abnormality of the collagen helix, and it is most likely that the over-modification of lysine, poor secretion, increased degradation and other fuctional sequelae result from a kinetic defect in collagen helix formation resulting from the mutation. |
Persistent Identifier | http://hdl.handle.net/10722/147338 |
ISSN | 2023 Impact Factor: 4.4 2023 SCImago Journal Rankings: 1.612 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Baker, AT | en_US |
dc.contributor.author | Ramshaw, RAM | en_US |
dc.contributor.author | Chan, D | en_US |
dc.contributor.author | Cole, WG | en_US |
dc.contributor.author | Bateman, JF | en_US |
dc.date.accessioned | 2012-05-29T06:03:01Z | - |
dc.date.available | 2012-05-29T06:03:01Z | - |
dc.date.issued | 1989 | en_US |
dc.identifier.citation | Biochemical Journal, 1989, v. 261 n. 1, p. 253-257 | en_US |
dc.identifier.issn | 0264-6021 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/147338 | - |
dc.description.abstract | The effect of glycine-to-arginine mutations in the α1(I)-chain on collagen triple-helix structure in lethal perinatal osteogenesis imperfecta was studied by determination of the helix denaturation temperature and by computerized molecular modelling. Arginine substitutions at glycine residues 391 and 667 resulted in similar small decreases in helix stability. Molecular modelling suggested that the glycine-to-arginine-391 mutant resulted in only a relatively small localized disruption to the helix structure. Thus the glycine-to-arginine substitutions may lead to only a small structural abnormality of the collagen helix, and it is most likely that the over-modification of lysine, poor secretion, increased degradation and other fuctional sequelae result from a kinetic defect in collagen helix formation resulting from the mutation. | en_US |
dc.language | eng | en_US |
dc.publisher | Portland Press Ltd. The Journal's web site is located at http://www.biochemj.org | en_US |
dc.relation.ispartof | Biochemical Journal | en_US |
dc.subject.mesh | Arginine | en_US |
dc.subject.mesh | Collagen - Genetics | en_US |
dc.subject.mesh | Drug Stability | en_US |
dc.subject.mesh | Glycine | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Infant, Newborn | en_US |
dc.subject.mesh | Models, Molecular | en_US |
dc.subject.mesh | Mutation | en_US |
dc.subject.mesh | Osteogenesis Imperfecta - Genetics - Metabolism | en_US |
dc.subject.mesh | Protein Conformation | en_US |
dc.subject.mesh | Protein Denaturation | en_US |
dc.title | Changes in collagen stability and folding in lethal perinatal osteogenesis imperfecta. The effect of α1(I)-chain glycine-to-arginine substitutions | en_US |
dc.type | Article | en_US |
dc.identifier.email | Chan, D:chand@hkucc.hku.hk | en_US |
dc.identifier.authority | Chan, D=rp00540 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1042/bj2610253 | - |
dc.identifier.pmid | 2775212 | - |
dc.identifier.scopus | eid_2-s2.0-0024391193 | en_US |
dc.identifier.volume | 261 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.spage | 253 | en_US |
dc.identifier.epage | 257 | en_US |
dc.identifier.isi | WOS:A1989AE78400037 | - |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.scopusauthorid | Baker, AT=7403520313 | en_US |
dc.identifier.scopusauthorid | Ramshaw, RAM=7004300244 | en_US |
dc.identifier.scopusauthorid | Chan, D=7402216545 | en_US |
dc.identifier.scopusauthorid | Cole, WG=7201518727 | en_US |
dc.identifier.scopusauthorid | Bateman, JF=16135557700 | en_US |
dc.identifier.issnl | 0264-6021 | - |